Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study

Dipeptidyl peptidase‐4 (DPP‐4), namely CD26, is expressed on the surface of immune cells, suggesting that inhibition of DPP‐4 might affect the immune system. The current multicenter observational case–control study was carried out to investigate the effects of DPP‐4 inhibitor (DPP‐4i) administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekizaki, Tomonori, Kameda, Hiraku, Nomoto, Hiroshi, Cho, Kyu Yong, Nakamura, Akinobu, Takahashi, Kiyohiko, Miyoshi, Arina, Wada, Norio, Takeuchi, Jun, Nagai, So, Miyoshi, Hideaki, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565407/
https://www.ncbi.nlm.nih.gov/pubmed/33998766
http://dx.doi.org/10.1111/jdi.13578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565407/
https://www.ncbi.nlm.nih.gov/pubmed/33998766
http://dx.doi.org/10.1111/jdi.13578

Ejemplares similares